PTHS
Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc. (PTHS) has 7 SEC Form 4 filings (13 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 7, 2026.
Insiders have net bought $896K over the trailing 6 months.
Insider Buying
$1000K
reported purchases (SEC code P)
Insider Selling
$104K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$98.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Greenleaf PeterFirst filing | Director | Sale | 797 | $21K | Jul 7 | SEC ↗ |
Pauls MatthewFirst filing | Director | Sale | 786 | $21K | Jul 7 | SEC ↗ |
| Director | Sale | 558 | $15K | Jul 7 | SEC ↗ | |
Friedberg Ezra MFirst filing | Director | Sale | 283 | $8K | Jun 17 | SEC ↗ |
Davis Todd CFirst filing | Director | Purchase | 35,948 | $1000K | Jun 15 | SEC ↗ |
Francis Knuettel IIFirst filing | CFO, Treas & Secty | Sale | 1,500 | $40K | May 26 | SEC ↗ |
Related companies
Pelthos Therapeutics Inc. is in the Healthcare sector.